US · SCL · CHEMICALS - SPECIALTY
Stepan Co (SCL) intrinsic value and stock valuation
$63.48as of 2026-11-21 · Mkt cap 1.46B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Stepan Co DCF and intrinsic value
InvestorsCraft values SCL with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from SCL’s statements →
Stepan Co Graham Number
Graham Number: $50.09d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- REX American Resources Corporation (REX) $33.94
- CVR Partners, LP (UAN) $95.09
- Oil-Dri Corporation of America (ODC) $68.27
- McEwen Mining Inc. (MUX) $9.18
- Ecovyst Inc. (ECVT) $9.00
- Green Plains Inc. (GPRE) $11.27
- Koppers Holdings Inc. (KOP) $29.04
- Braskem S.A. (BAK) $0.74
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.33B | $2.18B | $2.33B | $2.77B | $2.35B |
| Operating income | $69.4M | $70.5M | $58.6M | $207.3M | $170.8M |
| Net income | $46.9M | $50.4M | $40.2M | $147.2M | $137.8M |
| EPSd | $2.05M | $2.2M | $1.75M | $6.38M | $5.92M |
| Operating cash flow | $147.9M | $162.1M | $174.9M | $160.8M | $72.1M |
| Capital expenditure | -$-122.51M | -$-122.78M | -$-260.33M | -$-301.55M | -$-194.48M |
| Free cash flow | $25.4M | $39.3M | -$-85.46M | -$-140.79M | -$-122.35M |
| Total assets | $2.36B | $2.3B | $2.36B | $2.43B | $2.07B |
| Total debt | $691M | $682.8M | $712.2M | $637.7M | $420.3M |
| Net debt | $558.4M | $583.2M | $582.4M | $464M | $261.1M |
| Total equity | $1.24B | $1.17B | $1.22B | $1.17B | $1.07B |
| Cash and short-term investments | $132.7M | $99.7M | $129.8M | $173.8M | $159.2M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.33B | $2.18B | $2.33B | $2.77B | $2.35B |
| Cost of revenue | $2.06B | $1.91B | $2.05B | $2.35B | $1.95B |
| Gross profit | $269.9M | $272.2M | $277.6M | $427.1M | $395.8M |
| Research and development expenses | $59.3M | $55.7M | $59M | $66.6M | $62.7M |
| Selling, general and administrative expenses | $139.6M | $143.9M | $141.6M | $161.2M | $152.1M |
| Other expenses | $1.67M | $2.15M | $18.4M | -$-8.11M | $10.3M |
| Operating expenses | $200.5M | $201.7M | $219M | $219.7M | $225M |
| Cost and expenses | $2.26B | $2.11B | $2.27B | $2.57B | $2.18B |
| Interest income | $4.11M | $5.28M | $3.84M | $1.08M | $1.25M |
| Interest expense | $26.2M | $19.5M | $16M | $10.9M | $7.01M |
| Depreciation and amortization | $126M | $112.2M | $105.3M | $94.7M | $90.9M |
| Ebitda | $212.2M | $192.1M | $169.7M | $294.2M | $270.4M |
| Operating income | $69.4M | $70.5M | $58.6M | $207.3M | $170.8M |
| Total other income/expenses, net | -$-9.48M | -$-10.04M | -$-10.22M | -$-18.63M | $1.76M |
| Income before tax | $59.9M | $60.4M | $48.4M | $188.7M | $172.5M |
| Income tax expense | $13M | $10.1M | $8.19M | $41.6M | $34.6M |
| Net income | $46.9M | $50.4M | $40.2M | $147.2M | $137.8M |
| Weighted average shares outstanding | $22.9M | $22.9M | $22.8M | $22.8M | $22.9M |
| Weighted average diluted shares outstanding | $22.9M | $22.9M | $23M | $23.1M | $23.3M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $132.7M | $99.7M | $129.8M | $173.8M | $159.2M |
| Net receivables | $388M | $388M | $422.1M | $436.9M | $419.5M |
| Inventory | $298.8M | $288.7M | $265.6M | $402.5M | $305.5M |
| Total current assets | $859M | $810.4M | $851.9M | $1.04B | $913.4M |
| Property, plant and equipment, net | $1.28B | $1.27B | $1.28B | $1.07B | $850.6M |
| Goodwill and intangible assets | $132.1M | $134M | $150M | $154M | $158M |
| Long-term investments | $21.3M | $25.6M | $26.8M | $23.3M | $34.5M |
| Total non-current assets | $1.5B | $1.49B | $1.51B | $1.39B | $1.15B |
| Total assets | $2.36B | $2.3B | $2.36B | $2.43B | $2.07B |
| Accounts payable | $261.7M | $258.8M | $233M | $375.7M | $323.4M |
| Short-term debt | $300.7M | $292.8M | $252.9M | $132.1M | $40.7M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $666.5M | $669M | $607.9M | $670.7M | $500.5M |
| Long-term debt | $390.3M | $390M | $459.3M | $505.6M | $379.5M |
| Deferred revenue, non-current | $2.22M | $4.43M | $6.65M | $8.76M | $9.98M |
| Total non-current liabilities | $447.2M | $465.7M | $539M | $596.5M | $490.9M |
| Capital lease obligations | $49.3M | $57.4M | $58M | $50.6M | $56.7M |
| Total liabilities | $1.11B | $1.13B | $1.15B | $1.27B | $991.4M |
| Common stock | $27.3M | $27.2M | $27M | $26.8M | $26.8M |
| Retained earnings | $1.29B | $1.27B | $1.26B | $1.25B | $1.13B |
| Accumulated other comprehensive income (loss) | -$-138.97M | -$-196.84M | -$-130.6M | -$-167.51M | -$-153.24M |
| Total equity | $1.24B | $1.17B | $1.22B | $1.17B | $1.07B |
| Total investments | $21.3M | $25.6M | $26.8M | $23.3M | $34.5M |
| Total debt | $691M | $682.8M | $712.2M | $637.7M | $420.3M |
| Net debt | $558.4M | $583.2M | $582.4M | $464M | $261.1M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $46.9M | $50.4M | $40.2M | $147.2M | $137.9M |
| Depreciation and amortization | $126M | $112.2M | $105.3M | $94.7M | $90.9M |
| Stock-based compensation | $2.15M | $5.35M | $5.74M | $13.9M | $11.7M |
| Change in working capital | -$-22.04M | $2.79M | -$-1.93M | -$-68.96M | -$-141.51M |
| Accounts receivable | $23.7M | $9.04M | $32M | -$-54.17M | -$-104.23M |
| Inventory | $500K | -$-37.18M | $144.9M | -$-99.39M | -$-79.26M |
| Accounts payable | -$-32.71M | $34M | -$-158.92M | $54.2M | $44.4M |
| Net cash provided by operating activities | $147.9M | $162.1M | $174.9M | $160.8M | $72.1M |
| Investments in property, plant and equipment | -$-122.51M | -$-122.78M | -$-260.33M | -$-301.55M | -$-194.48M |
| Acquisitions, net | $26.6M | $0.00 | $0.00 | -$-9.69M | -$-184.47M |
| Net cash used for investing activities | -$-89.05M | -$-116.94M | -$-258.67M | -$-308.09M | -$-376.83M |
| Common stock issued | $100K | $1.11M | $2.79M | $780K | $1.37M |
| Common stock repurchased | $0.00 | $0.00 | $0.00 | -$-24.95M | -$-16.97M |
| Dividends paid | -$-35.03M | -$-33.95M | -$-32.87M | -$-30.57M | -$-28.08M |
| Net cash used for financing activities | -$-35.44M | -$-64.52M | $33.3M | $166.2M | $117.3M |
| Net change in cash | $33M | -$-30.16M | -$-43.93M | $14.6M | -$-190.75M |
| Cash at end of period | $132.7M | $99.7M | $129.8M | $173.8M | $159.2M |
| Operating cash flow | $147.9M | $162.1M | $174.9M | $160.8M | $72.1M |
| Capital expenditure | -$-122.51M | -$-122.78M | -$-260.33M | -$-301.55M | -$-194.48M |
| Free cash flow | $25.4M | $39.3M | -$-85.46M | -$-140.79M | -$-122.35M |
Line items
Line items
Line items
About Stepan Co
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, lubricating ingredients; emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites. The Polymers segment provides polyurethane polyols that are used in the manufacture of rigid foam for thermal insulation in the construction industry, as well as a base raw material for coatings, adhesives, sealants, and elastomers (CASE); polyester resins used in coating applications; specialty polyols, such as CASE and powdered polyester resins; and phthalic anhydride that is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. The Specialty Products segment offers flavors, emulsifiers, and solubilizers for use in food, flavoring, nutritional supplement, and pharmaceutical applications. Stepan Company was founded in 1932 and is headquartered in Northbrook, Illinois.
- CEO
- Luis E. Rojo
- Employees
- 2.33K
- Beta
- 0.95
Included in
Explore
Frequently asked questions
What is the intrinsic value of Stepan Co (SCL)?
Stepan Co (SCL) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is SCL undervalued?
SCL trades at a price of $63.48 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.